EHAB 📈 Enhabit - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29332G1022

EHAB: Home Health, Hospice Services

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas. Web URL: https://www.ehab.com

Additional Sources for EHAB Stock

EHAB Stock Overview

Market Cap in USD 383m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2022-07-01

EHAB Stock Ratings

Growth 5y -81.9%
Fundamental -51.2%
Dividend -
Rel. Strength Industry -633
Analysts 3/5
Fair Price Momentum 5.81 USD
Fair Price DCF 27.27 USD

EHAB Dividends

No Dividends Paid

EHAB Growth Ratios

Growth Correlation 3m 48.5%
Growth Correlation 12m -79.9%
Growth Correlation 5y -90.6%
CAGR 5y -37.66%
CAGR/Mean DD 5y -0.70
Sharpe Ratio 12m -0.44
Alpha -45.12
Beta 0.57
Volatility 64.22%
Current Volume 814.9k
Average Volume 20d 452.8k
What is the price of EHAB stocks?
As of December 22, 2024, the stock is trading at USD 7.65 with a total of 814,876 shares traded.
Over the past week, the price has changed by -10.21%, over one month by +2.55%, over three months by -4.97% and over the past year by -27.42%.
Is Enhabit a good stock to buy?
No, based on ValueRay Fundamental Analyses, Enhabit (NYSE:EHAB) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -51.21 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EHAB as of December 2024 is 5.81. This means that EHAB is currently overvalued and has a potential downside of -24.05%.
Is EHAB a buy, sell or hold?
Enhabit has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold EHAB.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for EHAB stock price target?
According to ValueRays Forecast Model, EHAB Enhabit will be worth about 6.3 in December 2025. The stock is currently trading at 7.65. This means that the stock has a potential downside of -18.04%.
Issuer Forecast Upside
Wallstreet Target Price 8.7 13.1%
Analysts Target Price 11.1 44.8%
ValueRay Target Price 6.3 -18%